“Matching-Adjusted Indirect Comparison (MAIC) of Deucravacitinib Versus Adalimumab for the Treatment of Patients With Moderate to Severe Plaque Psoriasis over 2 Years”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s112. https://doi.org/10.25251/skin.7.supp.112.